From Makhanda to Gqeberha to Jeffreys Bay: How Propella and TIA Catalyzed Innoeco’s Nanomedicine Journey
Securing the Technology Innovation Agency (TIA) Pre-Seed Fund through the Propella Business Incubator in Gqeberha marked a defining transition for Innoeco Lab Solutions, shifting our automated nanomedicine micro-factory concept from the formulation bench into verified industrial pathways. While grant funding provides essential runway, the true catalyst of incubation lies in high-touch mentorship, operational access, and strategic industry introductions.
Hands-On Incubation: Beyond the Boardroom
Incubation at Propella went far beyond administrative reviews and desk sessions. Hosted at Propella’s Gqeberha incubator building, Innoeco founders Pavesan Naidoo and Mendhi Dasram spent critical working sessions refining commercial strategy, clarifying unit economics, and aligning project milestones with the TIA deliverables schedule.
The hallmark of great business incubation is ecosystem leaders who actively open doors. Propella’s Grant Minnie took that mandate literally: loading Pavesan and Mendhi into the Propella bakkie and driving down the coast to Jeffreys Bay to facilitate a high-stakes, in-person facility visit with Value Added Life.
Having Grant Minnie accompany the founding team throughout the road trip, the boardroom meetings, and the factory floor inspection provided immediate institutional credibility and operational grounding, illustrating the standard for hands-on founder support.
Inside Value Added Life: Bridging Nanotechnology and Industrial Encapsulation
The visit to Value Added Life’s manufacturing operations in Jeffreys Bay provided a clear look into large-scale commercial GMP health manufacturing. Touring the facility alongside Managing Director Johan Lottering exposed the operational realities of high-volume encapsulation, pharmaceutical-grade cleanroom discipline, quality control pipelines, and commercial distribution channels.
The meeting established an immediate commercial synergy:
Innoeco's Deep-Tech IP: Proprietary nanoemulsion formulation, bioavailability enhancement, and automated micro-factory manufacturing capabilities.
Value Added Life's Industrial Scale: Established capsule manufacturing lines, expansive distribution footprints, and deep regulatory expertise across Southern African retail and healthcare sectors.
Shared Sovereign Vision: Replacing imported active formulations with domestically developed, nano-enhanced nutraceuticals and therapeutics capable of competing across African and European export corridors.
This engagement culminated in a formal Letter of Support from Value Added Life, validating Innoeco's technology and confirming mutual intent to co-develop and commercialize a next-generation pipeline of nanomedicine-based oral products at some point in the future.
What This Milestone Means for Innoeco
Third-Party Commercial Validation: Moving from academic and laboratory validation to an endorsement from an established industrial partner proves market appetite for domestic nanomedicine infrastructure.
De-risking the Technology Stack: TIA pre-seed backing allowed Innoeco to systematically procure equipment, validate the micro-factory reaction parameters, and establish baseline pilot batch metrics.
The Power of Ecosystem Alignment: The combination of government innovation funding (TIA), regional incubation leadership (Propella), and private-sector scale (Value Added Life) creates an actionable blueprint for scaling deep-tech ventures in South Africa.
Comments